A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.
about
Clinical Implications of Glucose Variability: Chronic Complications of DiabetesThe NIDDK Central Repository at 8 years--ambition, revision, use and impactStudy protocol of the Diabetes and Depression Study (DAD): a multi-center randomized controlled trial to compare the efficacy of a diabetes-specific cognitive behavioral group therapy versus sertraline in patients with major depression and poorly coDo data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes.Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic PatientsAssociation of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathyFluctuations in HbA1c are associated with a higher incidence of cardiovascular disease in Japanese patients with type 2 diabetesA Practical Review of C-Peptide Testing in DiabetesCognitive behavioural therapy in elderly type 2 diabetes patients with minor depression or mild major depression: study protocol of a randomized controlled trial (MIND-DIA).GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.Glycaemic variability affects ischaemia-induced angiogenesis in diabetic mice.Is A1C Variability an Independent Predictor for the Progression of Atherosclerosis in Type 2 Diabetic Patients?Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes.The role of blood pressure variability in the development of nephropathy in type 1 diabetesVisit-to-visit variability of fasting plasma glucose as predictor of ischemic stroke: competing risk analysis in a national cohort of Taiwan Diabetes Study.HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.Development and progression of diabetic retinopathy and associated risk factors in Korean patients with type 2 diabetes: the experience of a tertiary centerAerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial.A1C variability as an independent risk factor for microalbuminuria in young people with type 1 diabetes.HbA1C variability and the risk of renal status progression in Diabetes Mellitus: a meta-analysis.The relationship between glycemic variability and diabetic peripheral neuropathy in type 2 diabetes with well-controlled HbA1c.Utility of different glycemic control metrics for optimizing management of diabetesRelationship of HbA1c variability, absolute changes in HbA1c, and all-cause mortality in type 2 diabetes: a Danish population-based prospective observational studyHbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patientsBoth high and low HbA1c predict incident heart failure in type 2 diabetes mellitusUrinary matrix metalloproteinase activities: biomarkers for plaque angiogenesis and nephropathy in diabetes.Association between Visit-to-Visit Glucose Variability and Cognitive Function in Aged Type 2 Diabetic Patients: A Cross-Sectional StudyThe association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.Plantar fascia thickness is longitudinally associated with retinopathy and renal dysfunction: a prospective study from adolescence to adulthoodExcessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitusEndothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion.Glycemic variability in patients with Wolfram syndrome is lower than in type 1 diabetes.Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.Risk factors associated with diabetic retinopathy onset and progression in diabetes patients: a Taiwanese cohort study.Insulin analogues in children with Type 1 diabetes: a 52-week randomized clinical trialLimitations and future treatment options in type 2 diabetes with renal impairment.Sugar and bone: a not-so sweet story.Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.
P2860
Q26801671-6DAF7610-5229-4DE8-A122-F5CC542D7771Q28741095-28D1AD5E-2AD6-4737-A1B4-9ED4727126E2Q30543384-125FB72A-689D-4C27-9310-B09E7A122073Q30666747-C253B225-CC4B-4AA3-9CE1-2BE61567EB1DQ30992797-D9068BDF-2952-47F8-9328-FA4C48CDEEAAQ31013668-78149F17-5FEB-4CF3-8A28-1AE333953FD7Q33537437-0D9DB5C5-0CF7-4856-B12F-41DE3D4446CBQ33609799-44AFFA78-C531-4384-81F8-CD41A7FA023FQ33732640-3D7A6EFF-4C21-4C38-B821-FD69391B6C47Q33881775-8EEB4BE3-055F-44D7-9AE1-15B7538FFA94Q33884211-087D3DF0-4A17-4253-A335-48C77B13EC18Q33950813-2EBDF8D4-455E-4213-B06C-99E4D9476C10Q33969587-AE9C1502-EA5C-4437-A575-BD276DAA3E65Q34064565-F2152C6A-CE32-478F-B529-5379AA76A973Q34237456-F689DE18-E09C-4876-957E-B1E38C17357CQ34278597-DF5A031F-5036-4575-A796-9F33700F7212Q34546548-B27617EF-5C4E-43F5-B5B1-3743F1FFC722Q34592013-BE664A0A-3895-4914-9B20-62C8D1F56472Q34639013-F2CCB36F-E3B9-4BB7-94C4-6C9E91EA68E7Q34718250-91E8D3BF-0387-4B29-87E2-4672837D8C51Q34734227-44702669-B771-4847-BD71-422754515E43Q34748572-F1C935E2-B595-4DF0-9DD1-672F664ECC8DQ35049855-A4AE4052-8A0F-492E-8EE7-47968D9FF7E7Q35050565-83104137-8155-4A58-9DF7-6599F38EE020Q35114974-6F3C2F5D-9FB8-43F9-97C5-6F513E260E45Q35197212-571B99DC-097C-47C3-8365-DF7342CC0061Q35601594-0985A95A-8A12-4269-9DA1-BE7B67F030A5Q35679968-2420D982-FC6A-4850-A850-4DB2FBC592D8Q35711866-D239C00C-E26F-47C5-BD62-5BC17829CB5BQ36051272-91B7C5EC-04BD-480F-A5D6-8C9D5C79F20DQ36069564-2A2E2CB4-B4DE-4E07-B8EE-8F80118F0880Q36111664-609553C0-907D-4899-BD55-F97E89E35259Q36229266-514EFCB8-4A6F-491A-A1E0-ED46C2B1B8E1Q36234364-FAB73393-9227-4989-8C04-9123C626D852Q36297813-BC4D7BE5-2B44-4B47-AB6E-9EAEC6E61FBBQ36493168-1E1D3034-B6E1-486F-9407-E1467F841952Q36629167-59309CBD-4457-4202-A5A5-AB9B0DCB6CD4Q36783886-83C800C7-1EA3-44F8-B62E-8A993215A5DDQ36984862-C6B3FD0A-674E-434B-A07B-17DAB2052A8AQ37000730-1E5EB485-DE11-4A86-93F8-8F526741E242
P2860
A1C variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A1C variability and the risk o ...... ntrol and Complications Trial.
@ast
A1C variability and the risk o ...... ntrol and Complications Trial.
@en
type
label
A1C variability and the risk o ...... ntrol and Complications Trial.
@ast
A1C variability and the risk o ...... ntrol and Complications Trial.
@en
prefLabel
A1C variability and the risk o ...... ntrol and Complications Trial.
@ast
A1C variability and the risk o ...... ntrol and Complications Trial.
@en
P2860
P356
P1433
P1476
A1C variability and the risk o ...... ntrol and Complications Trial.
@en
P2093
Alan S Rigby
Eric S Kilpatrick
P2860
P304
P356
10.2337/DC08-0864
P407
P577
2008-07-23T00:00:00Z